IGF-1 LR3 1MG

IGF-1 LR3 (Insulin-like Growth Factor 1 Long-R3) is a recombinant human peptide derived from the natural insulin-like growth factor 1 sequence with the addition of three proline residues at the C-terminus. This variant is widely utilized in scientific research for studying growth factor mechanisms, cellular signaling pathways, and potential therapeutic implications under controlled conditions.

Key Research Focus Areas

• Supports muscle growth, repair, and recovery
• Studied for protein synthesis and cellular growth signaling pathways

Research Context

IGF-1 and its variants, including LR3, play crucial roles in growth, development, metabolism, and aging. The LR3 modification is often used to enhance peptide stability and extend circulation times in biological systems. This variant has been studied extensively in models such as mice, rats, and cell cultures to elucidate its effects on gene expression, protein synthesis, and tissue regeneration.

Research Overview

IGF-1 LR3 is typically synthesized using recombinant DNA technology to ensure consistency in sequence and purity. Research applications may include investigations into the molecular mechanisms of IGF-1 signaling, the impact of growth factors on cancer biology, and the development of novel treatments for age-related degenerative diseases. Due to its potential modulatory effects, it is essential to conduct research under strict regulatory oversight to ensure safety and reproducibility.

Safety and Compliance

IGF-1 LR3 1MG is intended solely for research purposes and should be handled with caution. All research involving peptides must adhere to institutional guidelines, ethical standards, and regulatory requirements applicable to the specific experimental model. Proper sterile technique, appropriate storage conditions (typically -20°C or lower), and controlled access to the material are critical to maintain its integrity.

For research use only. Not for human or animal consumption.